PsyAccess
Am I eligible?
Am I eligible?
Spravato®Registry-verifiedDesignated-centers model

Psychiatrie Baselland (PBL)

Liestal, Switzerland

Treatment & access

  • Treatments offeredEsketamine nasal spray (Spravato®)
  • Access routeCovered by a national programme
  • Cost & coverage (registry status)Reimbursed by mandatory health insurance (OKP/AOS) per SL Limitatio
  • ReimbursementBAG Spezialitätenliste Limitatio: cantonal psychiatric care mandate required; list valid 2025-10-01 to 2028-09-30 How reimbursement works in Europe →
  • Phone+41 61 553 56 56
  • Websitehttps://www.pbl.ch

About this provider

Psychiatrie Baselland (PBL) is the public psychiatric provider for the canton of Basel-Landschaft, headquartered at Bienentalstrasse 7 in Liestal and named on the official BAG list of designated Spravato centres. Its depression and burnout care spans outpatient clinics in Liestal, Binningen and Muenchenstein, a day clinic in Muenchenstein and inpatient wards, combining psychotherapy (including mentalization-based therapy), medication, creative and body-oriented therapies and social-service support. PBL's public pages do not describe an esketamine programme; ask the central admission office about eligibility.

Services & programs

  • Outpatient diagnostics, counselling and treatment for depression and burnout at the Liestal, Binningen and Muenchenstein clinics
  • Day clinic treatment in Muenchenstein (4.5 days per week programme)
  • Inpatient depression treatment with an individual treatment plan
  • Medication-based (pharmacological) therapies
  • Psychotherapy in individual and group formats, framed by mentalization-based therapy (MBT)
  • Art therapy, animal-assisted therapy, recovery groups and internal social service

Common questions

Is Spravato (esketamine) covered by insurance at Psychiatrie Baselland?

PBL is on the BAG list of designated Spravato centres. Under the Swiss Limitatio, basic insurance (OKP) reimburses esketamine nasal spray for adults aged 18-74 with treatment-resistant depression - at least two adequate antidepressant trials plus one augmentation attempt without sufficient response and illness severity of CGI-S 5 or higher - subject to prior insurer approval (Kostengutsprache) and a maximum of 10 months of treatment.

How do I get access to treatment at PBL?

Contact the Zentrale Aufnahme (central admission) in Liestal on +41 61 553 56 56. You can register yourself or be referred by your treating physician; the admission team directs you to the appropriate outpatient, day-clinic or inpatient service.

Does PBL publish details of its esketamine programme?

No. PBL's public depression pages describe psychotherapeutic, pharmacological and rehabilitative treatment but do not list an esketamine service. Since PBL appears on the official BAG centre list, ask the admission office directly whether you meet the criteria for esketamine treatment.

Looking at alternatives? One of the BAG-designated Spravato centers; see the country guide and the limited-medical-use PAT program.

37 more verified providers within 50 km

See them on the provider map →

Verification

Re-checked every 90 days · how we verify and report corrections

Check your fit & enquire

Check my fit & enquire

Free 2-minute pre-screening in your browser · your summary goes only to Psychiatrie Baselland (PBL), with your consent.

What to prepare before you enquire

  • A referral or the contact details of your treating clinician
  • A list of medications you have tried (names, doses, duration)
  • A short diagnosis summary or discharge letters

Esketamine programmes usually require a documented history of antidepressant treatment.

Send documents directly to the provider when they reply. We never ask you to upload medical records.

Check my fit & enquire